Ticagrelor And Aspirin For The Prevention Of Cardiovascular Events After Coronary Artery Bypass Surgery: The Tap-Cabg Study

Jacqueline W L Saw,Graham Wong,John R Mayo, Vicki Bernstein,G B John Mancini,Jian Ye,Peter Skarsgard,Andrew Starovoytov, Rebecca S Fox,John A Cairns

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2015）

引用 2|浏览7

暂无评分

摘要

Ticagrelor reduced mortality by 51% in patients who underwent coronary artery bypass grafting (CABG) in the PLATO study, but its effect on graft patency is unknown.We performed a prospective, randomized, blinded, placebo-controlled trial, comparing ticagrelor 90mg bid versus placebo for 3 months

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要